InsidersTradesSigma
Follow the 지투지바이오 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 지투지바이오 has published 8 insider filings. Market capitalisation: €618.8bn. The latest transaction was reported on 5 June 2026 (Purchase). Among the most active insiders: 이희용. The full history is openly available.
6
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
1 ops.
Sell Volume
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 June 2026
Declarations8 total
Other
Other
8 of 8 declarations
Acerca de 지투지바이오
지투지바이오 es una empresa de salud y farmacéutica que cotiza en el mercado XKRX. Se enfoca en el desarrollo de soluciones biofarmacéuticas innovadoras.